Equities

Benchmark Holdings PLC

Benchmark Holdings PLC

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (GBX)37.25
  • Today's Change-0.25 / -0.67%
  • Shares traded48.92k
  • 1 Year change-32.27%
  • Beta0.9245
Data delayed at least 20 minutes, as of Feb 08 2023 16:28 GMT.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Key statistics

On Wednesday, Benchmark Holdings PLC (BMK:LSE) closed at 37.25, 6.43% above its 52-week low of 35.00, set on Oct 13, 2022.
52-week range
Today
35.00Oct 13 202257.00Feb 16 2022
Markit short selling activity
Low
Med
High
Open37.00
High37.50
Low37.00
Bid37.00
Offer60.00
Previous close37.50
Average volume376.82k
Shares outstanding739.20m
Free float533.00m
P/E (TTM)--
Market cap277.20m GBP
EPS (TTM)-0.0458
GBP
Data delayed at least 20 minutes, as of Feb 08 2023 16:28 GMT.
More ▼

Investors Chronicle View

The last IC recommendation on Benchmark Holdings PLC shares was Hold at 37.00 on 30 Nov 2022Read the full article
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.